Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. USO
6. AMD
7. TSLA
8. META
9. ACN
10. COHR

Go back to Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million
(NYSE: BHVN) Delayed: 14.22 --0 (-0%)
Previous Close $14.22    52 Week High $ 
Open $14.22    52 Week Low $ 
Day High $14.22    P/E N/A 
Day Low $14.22    EPS $ 
Volume 1       

REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.44 --0 (-0%)
Previous Close $58.44    52 Week High $3.48 
Open $58.44    52 Week Low $0.80 
Day High $58.44    P/E N/A 
Day Low $58.44    EPS $-1.54 
Volume 5